# Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

> **NCT02909153** · PHASE1 · COMPLETED · sponsor: **Rockwell Medical Technologies, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Peritoneal Dialysis (PD)
- Anemia
- Chronic Kidney Disease

## Interventions

- **DRUG:** Triferic

## Key facts

- **NCT ID:** NCT02909153
- **Lead sponsor:** Rockwell Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02909153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02909153, "Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02909153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*